nsv4681360
- Organism: Homo sapiens
- Study:nstd102 (Clinical Structural Variants)
- Variant Type:copy number variation
- Method Type:Multiple
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: Yes
- Region Size:892
- Description:NC_000009.12:g.(?_95449059)_(95449950_?)del AND Gorlin syndrome
- Publication(s):Evans et al. 2002, Hampel et al. 2014, Lo Muzio et al. 2011, No authors et al. 2021, No authors et al. 2021, No authors et al. 2021, Trepanier et al. 2004
- ClinVar: RCV001031991.6
- ClinVar: VCV000831435.8
- GeneReviews: NBK1151
- MONDO: 0007187
- MedGen: C0004779
- OMIM: 109400
- OMIM: 601309.0001
- OMIM: 601309.0002
- OMIM: 601309.0003
- OMIM: 601309.0004
- OMIM: 601309.0005
- OMIM: 601309.0006
- OMIM: 601309.0007
- OMIM: 601309.0008
- OMIM: 601309.0016
- OMIM: 601309.0017
- Orphanet: 377
- PubMed: 15604628
- PubMed: 20301330
- PubMed: 21304560
- PubMed: 25394175
- PubMed: 26389210
- PubMed: 26389258
- PubMed: 26389333
- Overlapping Genes
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 59 SVs from 20 studies. See in: genome view
Overlapping variant regions from other studies: 59 SVs from 20 studies. See in: genome view
Variant Region Placement Information
| Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
|---|---|---|---|---|---|---|---|---|---|
| nsv4681360 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000009.12 | Chr9 | 95,449,059 | 95,449,950 |
| nsv4681360 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000009.11 | Chr9 | 98,211,341 | 98,212,232 |
Variant Call Information
| Variant Call ID | Type | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
|---|---|---|---|---|---|---|---|
| nssv16213670 | deletion | Multiple | Multiple | BASAL CELL NEVUS SYNDROME; BCNS; Gorlin syndrome; Gorlin syndrome; Nevoid Basal Cell Carcinoma Syndrome; See individual phenotypes in OMIM allelic variants | Pathogenic | ClinVar | RCV001031991.6, VCV000831435.8 |
Variant Call Placement Information
| Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
|---|---|---|---|---|---|---|---|---|---|
| nssv16213670 | Remapped | Perfect | NC_000009.12:g.(?_ 95449059)_(9544995 0_?)del | GRCh38.p12 | First Pass | NC_000009.12 | Chr9 | 95,449,059 | 95,449,950 |
| nssv16213670 | Submitted genomic | NC_000009.11:g.(?_ 98211341)_(9821223 2_?)del | GRCh37 (hg19) | NC_000009.11 | Chr9 | 98,211,341 | 98,212,232 |
No validation data were submitted for this variant
Clinical Assertions
| Variant Call ID | HGVS | Type | Allele Origin | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
|---|---|---|---|---|---|---|---|
| nssv16213670 | GRCh37: NC_000009.11:g.(?_98211341)_(98212232_?)del | deletion | germline | BASAL CELL NEVUS SYNDROME; BCNS; Gorlin syndrome; Gorlin syndrome; Nevoid Basal Cell Carcinoma Syndrome; See individual phenotypes in OMIM allelic variants | Pathogenic | ClinVar | RCV001031991.6, VCV000831435.8 |